Search company, investor...

Halo Healthcare

halohc.com

Founded Year

2000

Stage

Debt | Alive

Total Raised

$5.22M

Last Raised

$4.22M | 11 yrs ago

About Halo Healthcare

Halo Healthcare, formerly NeoMatrix, develops devices that allow women and doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test, is a fully automated, non-invasive breast cancer risk assessment device designed for use in the primary care setting as part of an annual well-woman visit. The HALO Breast Pap Test is FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre-malignant versus malignant cells.

Headquarters Location

19800 MacArthur Blvd Suite 650

Irvine, California, 92612,

United States

Missing: Halo Healthcare's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Halo Healthcare's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Halo Healthcare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Halo Healthcare is included in 2 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

W

Women's Health & Wellness

1,484 items

Startups focused on providing products and services catering to women's health and wellbeing.

Halo Healthcare Patents

Halo Healthcare has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/27/2014

Dosage forms, Drug delivery devices, Elasticity (physics), Vacuum systems, Mechanics

Application

Application Date

5/27/2014

Grant Date

Title

Related Topics

Dosage forms, Drug delivery devices, Elasticity (physics), Vacuum systems, Mechanics

Status

Application

Halo Healthcare Frequently Asked Questions (FAQ)

  • When was Halo Healthcare founded?

    Halo Healthcare was founded in 2000.

  • Where is Halo Healthcare's headquarters?

    Halo Healthcare's headquarters is located at 19800 MacArthur Blvd, Irvine.

  • What is Halo Healthcare's latest funding round?

    Halo Healthcare's latest funding round is Debt.

  • How much did Halo Healthcare raise?

    Halo Healthcare raised a total of $5.22M.

  • Who are Halo Healthcare's competitors?

    Competitors of Halo Healthcare include NeoChord, CivaTech Oncology, Seno Medical Instruments, Micrima, Armune Bioscience and 11 more.

Compare Halo Healthcare to Competitors

M
Manoa Medical

Manoa Medical develops an advanced method of diagnosis and treatment of breast cancer.

B
Bioluminate

The company's primary goals are to eliminate unnecessary breast surgeries, find the breast cancers that are often missed, facilitate the therapy delivery process, and save the company's healthcare system $2.3 billion annually. n

M
Michelson Diagnostics

Michelson Diagnostics (MDL) is a UK-based independent company with products based on an optical imaging technology, called 'Multi-Beam OCT'. The company is primarily targeting cancer (screening, diagnosis, staging, treatment planning and guidance, and monitoring), but the products are also finding applications in commercial skin products research, in genetics (developmental biology) and in industrial metrology.

O
Orison

Orison Corporation was founded to design, manufacture and market a ultrasound technology platform for early breast cancer detection and diagnosis. Orison's technology aims to utilize Full Field Digital Ultrasound (FDDU) as an enabler that aims to allow the radiologist, for a time, to view breast tissue in a three dimensional environment. The outcome is earlier detection of breast cancer prior to metastasis, resulting in greater five-year survival rates and decreased treatment costs.

Micrima Logo
Micrima

Micrima is a Bristol-based company developing a safe, low-cost system to improve the detection of breast cancer. The imaging system captures high-resolution, 3D images through the use of harmless radio waves. The safe, low-cost system enables women of all ages to be screened for breast cancer in GP surgeries, or alternative high street locations, with results that are now comparable with traditional X-ray mammograms.

R
Real Imaging

Real Imaging is developing an imaging solution for breast cancer detection which is both accurate and patient-friendly. Real imaging's MIRA technology will increase correct detection rates and decrease the amount of false diagnoses for women of all ages around the globe.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.